Science

Felipe Couñago: Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients

Felipe Couñago/X

Jan 6, 2025, 14:37

Felipe Couñago: Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients

Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a recent article on X:

“Our last paper is out: Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients – a real-world single institution experience.

Thank you very much Renza Ghalehtaki, MD, and team for including me in this project.”

Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experience

Authors: Reza Ghalehtaki, Kasra Kolahdouzan, Guglielmo Niccolò Piozzi, Saeid Rezaei, Zoha Shaka, Nima Mousavi Darzikolaee, Reyhaneh Bayani, Behnam Behboudi, Mahdi Aghili, Felipe Couñago, Azadeh Sharifian, Farzaneh Bagheri, Reza Nazari, Naeim Nabian, Mohammad Babaei, Mohsen Ahmadi Tafti, Mohammadsadegh Fazeli and Farshid Farhan

chemoradiotherapyrectal cancerFelipe Couñago

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Science

OncoDaily

Science

Felipe Couñago: Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients